Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Rattus norvegicus | Small conductance calcium-activated potassium channel | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus multilocularis | small conductance calcium activated potassium | Small conductance calcium-activated potassium channel | 580 aa | 475 aa | 48.0 % |
Echinococcus granulosus | small conductance calcium activated potassium | Small conductance calcium-activated potassium channel | 580 aa | 475 aa | 48.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | tumor protein p63 | 0.0341 | 1 | 1 |
Echinococcus multilocularis | small conductance calcium activated potassium | 0.019 | 0.4811 | 0.4664 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0058 | 0.0274 | 0.5 |
Echinococcus granulosus | small conductance calcium activated potassium | 0.019 | 0.4811 | 0.4664 |
Schistosoma mansoni | calcium-activated potassium channel | 0.019 | 0.4811 | 1 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0058 | 0.0274 | 0.5 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0058 | 0.0274 | 0.0403 |
Brugia malayi | follicle stimulating hormone receptor | 0.0234 | 0.6315 | 0.974 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0054 | 0.014 | 0.0216 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0239 | 0.6484 | 0.6384 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0014 | 0.0021 |
Schistosoma mansoni | hypothetical protein | 0.019 | 0.4811 | 1 |
Onchocerca volvulus | 0.005 | 0 | 0.5 | |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.1221 | 0.1883 |
Brugia malayi | hypothetical protein | 0.0239 | 0.6484 | 1 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0239 | 0.6484 | 0.6384 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0058 | 0.0274 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.019 | 0.4811 | 0.742 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.005 | 0.0014 | 0.0021 |
Loa Loa (eye worm) | follicle stimulating hormone receptor | 0.0234 | 0.6315 | 0.974 |
Loa Loa (eye worm) | hypothetical protein | 0.0095 | 0.1557 | 0.2401 |
Schistosoma mansoni | calcium-activated potassium channel | 0.0181 | 0.4492 | 0.9339 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0058 | 0.0274 | 0.057 |
Loa Loa (eye worm) | hypothetical protein | 0.0239 | 0.6484 | 1 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0058 | 0.0274 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Displacement (binding) | = 23 % | Displacement of [125I]-apamin from calcium-activated potassium (SK) channels of rat cortex at 10 uM | ChEMBL. | 16033276 |
Displacement (binding) | = 23 % | Displacement of [125I]-apamin from calcium-activated potassium (SK) channels of rat cortex at 10 uM | ChEMBL. | 16033276 |
IC50 (binding) | = 50 uM | Inhibition of [125I]-apamin binding to calcium-activated potassium (SK) channel of rat cortex | ChEMBL. | 16033276 |
IC50 (binding) | = 50 uM | Inhibition of [125I]-apamin binding to calcium-activated potassium (SK) channel of rat cortex | ChEMBL. | 16033276 |
Ki (binding) | = 9.3 uM | Inhibition of [125I]-apamin binding to calcium-activated potassium (SK) channel of rat cortex | ChEMBL. | 16033276 |
Ki (binding) | = 9.3 uM | Inhibition of [125I]-apamin binding to calcium-activated potassium (SK) channel of rat cortex | ChEMBL. | 16033276 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.